Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$0.29 - $0.89 $23,315 - $71,553
80,397 New
80,397 $22,000
Q1 2022

May 16, 2022

SELL
$1.07 - $2.71 $93,490 - $236,783
-87,374 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$1.87 - $2.91 $71,426 - $111,150
38,196 Added 77.67%
87,374 $166,000
Q3 2021

Nov 15, 2021

BUY
$3.01 - $4.12 $78,253 - $107,111
25,998 Added 112.16%
49,178 $148,000
Q2 2021

Aug 16, 2021

BUY
$3.62 - $5.23 $46,676 - $67,435
12,894 Added 125.35%
23,180 $91,000
Q1 2021

May 17, 2021

SELL
$3.94 - $8.19 $549,054 - $1.14 Million
-139,354 Reduced 93.13%
10,286 $52,000
Q4 2020

Feb 16, 2021

BUY
$3.99 - $5.7 $451,983 - $645,690
113,279 Added 311.54%
149,640 $612,000
Q3 2020

Nov 16, 2020

SELL
$4.38 - $6.43 $365,458 - $536,506
-83,438 Reduced 69.65%
36,361 $177,000
Q2 2020

Aug 14, 2020

BUY
$3.0 - $6.9 $20,541 - $47,244
6,847 Added 6.06%
119,799 $664,000
Q1 2020

May 15, 2020

BUY
$2.36 - $9.86 $112,763 - $471,120
47,781 Added 73.32%
112,952 $370,000
Q4 2019

Feb 14, 2020

SELL
$2.69 - $4.92 $14,243 - $26,051
-5,295 Reduced 7.51%
65,171 $295,000
Q3 2019

Nov 14, 2019

SELL
$2.59 - $4.16 $94,537 - $151,844
-36,501 Reduced 34.12%
70,466 $293,000
Q2 2019

Aug 14, 2019

SELL
$3.6 - $4.78 $120,657 - $160,206
-33,516 Reduced 23.86%
106,967 $405,000
Q1 2019

May 15, 2019

SELL
$2.62 - $4.44 $173,022 - $293,213
-66,039 Reduced 31.98%
140,483 $589,000
Q4 2018

Feb 14, 2019

BUY
$2.28 - $7.15 $185,249 - $580,937
81,250 Added 64.86%
206,522 $514,000
Q3 2018

Nov 14, 2018

BUY
$3.85 - $7.35 $482,297 - $920,749
125,272 New
125,272 $914,000
Q2 2018

Aug 14, 2018

BUY
$3.7 - $5.65 $120,220 - $183,579
32,492 New
32,492 $120,000
Q1 2018

May 15, 2018

SELL
$3.65 - $5.2 $222,255 - $316,638
-60,892 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$3.4 - $4.15 $47,637 - $58,145
14,011 Added 29.89%
60,892 $219,000
Q3 2017

Nov 14, 2017

BUY
$3.55 - $5.25 $166,427 - $246,125
46,881
46,881 $185,000

About APPLIED GENETIC TECHNOLOGIES CORP


  • Ticker AGTC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,632,200
  • Description
  • Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...
More about AGTC
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.